Treatment of Androgenetic Alopecia by Exosomes Secreted from Hair Papilla Cells and the Intervention Effect of LTF
Overview
Authors
Affiliations
Background: Androgenetic alopecia (AGA) is the most common cause of chronic progressive hair loss in men, and AGA has a severe negative impact on the quality of life and physical and mental health of patients.
Methods: Four female C57BL/6 mice were isolated from DP cells in culture (≤4 generations) after stimulation of DPC proliferation by herbal concentrations obtained by the CCK-8 method, and exosomes were isolated by differential centrifugation at low temperature. Testosterone propionate and topical hair removal treatments were used together to establish the C57BL/6 mouse AGA model, which was treated with LTF, 5% minoxidil, and LTF-DPC-EXO, respectively. ELISA was used to detect serum hormone levels, in vivo tracing was used to observe dynamic changes in exosomes, H&E staining showed changes in mouse hair follicle tissue, and (q) RT-PCR and WB were used to detect dorsal skin VEGF, AKT1, and CASP3 expression in dorsal skin tissues.
Results: Hair regeneration was significant in the LTF group, minoxidil group, and LTF-DPC-EXO group mice, and the hair growth was only seen in the local skin in the model group. The hormone T in all treatment groups was lower than that in the model group, and e2 was higher than that in the model group. (q) RT-PCR and western blot showed that VEGF and AKT1 expressions were upregulated and Caspase3 expression was downregulated in the skin sections of mice in the treatment groups.
Conclusion: DPC-EXO obtained through LTF may activate AKT1 and VEGF in the PI3K/AKT signaling pathway to inhibit CASP3, thereby protecting DPC to restore the hair growth.
Chu S, Jia L, Li Y, Xiong J, Sun Y, Zhou Q Clin Transl Med. 2025; 15(1):e70152.
PMID: 39748192 PMC: 11695201. DOI: 10.1002/ctm2.70152.
Exploring the reality of exosomes in dermatology.
DalForno-Dini T, Birck M, Rocha M, Bagatin E An Bras Dermatol. 2024; 100(1):121-130.
PMID: 39562240 PMC: 11745280. DOI: 10.1016/j.abd.2024.09.002.
Effectiveness of Exosome Treatment in Androgenetic Alopecia: Outcomes of a Prospective Study.
Ersan M, Ozer E, Akin O, Tasli P, Sahin F Aesthetic Plast Surg. 2024; 48(21):4262-4271.
PMID: 39174804 PMC: 11588828. DOI: 10.1007/s00266-024-04332-3.
Network Pharmacology Reveals Roxb. Regulates MAPK and HIF-1 Pathways to Treat Androgenetic Alopecia.
Sintos A, Cabrera H Biology (Basel). 2024; 13(7).
PMID: 39056691 PMC: 11274231. DOI: 10.3390/biology13070497.